Literature DB >> 36202920

Imaging features and biopsy yield of soft tissue metastatic lesions: 10-year single tertiary center experience.

Marisa Ilag1, Christopher Burke2, William R Walter2, Mohammad Samim2.   

Abstract

OBJECTIVE: To evaluate imaging features of soft tissue metastases, technical factors associated with diagnostic yield of image-guided biopsy, and clinical impact of biopsy results on patient outcomes.
MATERIALS AND METHODS: A total of 1605 image-guided soft tissue biopsies were retrospectively identified from December 2010 to December 2020. Included lesions were histologically proven musculoskeletal soft tissue metastases. Lesions were excluded if intraabdominal, intrathoracic, retroperitoneal, associated with osseous lesions or surgical scar implants or arising from skin or lymph nodes. Image guidance modality, needle size, number of cores, and lesion location, size, and depth from skin were recorded. Patient demographics, malignancy history, biopsy-driven changes in management, and survival rate after biopsy were collected.
RESULTS: Forty-six patients met the inclusion criteria with a biopsy diagnostic yield of 44/46 (95.7%). Metastases were most commonly located truncal (82.6%, p < 0.001) and intramuscular (78.3%, p < 0.001). A total of 37/46 (80.4%) biopsies were US-guided. And 9/46 (19.6%) were CT-guided. There was no significant difference in the number of cores or mean needle gauge between diagnostic and nondiagnostic biopsies. At time of review, 23 (50%) patients were deceased, with a mean survival of 13.5 months after biopsy. The majority (71.7%) of patients had a known primary malignancy at time of biopsy, most commonly lung (24.2%) and breast (24.2%). Overall survival showed no association with anatomic location (p > 0.83) or tissue type (p > 0.34). The most common biopsy-driven outcome was initiation of chemotherapy, immunotherapy, and/or radiotherapy (52.2%).
CONCLUSION: Image-guided biopsy for soft tissue metastases has high diagnostic yield and commonly influences clinical management. Metastases were most commonly intramuscular in the trunk and are associated with poor prognosis.
© 2022. The Author(s), under exclusive licence to International Skeletal Society (ISS).

Entities:  

Keywords:  Biopsy yield; Image-guided biopsy; Soft tissue metastasis

Year:  2022        PMID: 36202920     DOI: 10.1007/s00256-022-04197-0

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.128


  6 in total

1.  Ultrasound guided core needle biopsy of soft tissue tumors; a fool proof technique?

Authors:  Siegfried Peer; Tamara Freuis; Alexander Loizides; Hannes Gruber
Journal:  Med Ultrason       Date:  2011-09       Impact factor: 1.611

2.  Shear-Wave Elastography of Benign versus Malignant Musculoskeletal Soft-Tissue Masses: Comparison with Conventional US and MRI.

Authors:  Aniket N Tavare; Abdulrahman M Alfuraih; Elizabeth M A Hensor; Emmanouil Astrinakis; Harun Gupta; Philip Robinson
Journal:  Radiology       Date:  2018-11-27       Impact factor: 11.105

3.  Skeletal muscle metastases: primary tumours, prevalence, and radiological features.

Authors:  Alexey Surov; Michael Hainz; Hans-Jürgen Holzhausen; Dirk Arnold; Michaela Katzer; Joerg Schmidt; Rolf Peter Spielmann; Curd Behrmann
Journal:  Eur Radiol       Date:  2009-08-26       Impact factor: 5.315

4.  Skeletal muscle metastases of carcinoma: a clinicopathological study of 12 cases.

Authors:  Yilihamu Tuoheti; Kyoji Okada; Toshihisa Osanai; Jun Nishida; Shigeru Ehara; Manabu Hashimoto; Eiji Itoi
Journal:  Jpn J Clin Oncol       Date:  2004-04       Impact factor: 3.019

5.  Doppler ultrasound for diagnosis of soft tissue sarcoma: efficacy of ultrasound-based screening score.

Authors:  Satoshi Nagano; Yuhei Yahiro; Masahiro Yokouchi; Takao Setoguchi; Yasuhiro Ishidou; Hiromi Sasaki; Hirofumi Shimada; Ichiro Kawamura; Setsuro Komiya
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

6.  Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT.

Authors:  Nghi C Nguyen; Bassem T Chaar; Medhat M Osman
Journal:  BMC Med Imaging       Date:  2007-12-12       Impact factor: 1.930

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.